Antidepressant Treatment of AIDS Related Depression.

Study Overview
=================
Brief Summary
-----------------
To test the effectiveness treating AIDS related depression with imipramine hydrochloride. Depression syndromes are commonly associated with chronic, disabling, and fatal diseases. Due to the relentless course of HIV infection, there is a certain reluctance to treat the associated depression. In other illness, it has been proven that treating the depression often results in improvement of overall health status. This is a placebo controlled trial. Half of the patients are given imipramine hydrochloride every day for 6 weeks. Assessment is done by self reports and the Hamilton Depression Rating Scale. Prior to entry all patients are given a psychiatric evaluation. There is a cross over phase in which placebo non responders are entered into an open-label study and given imipramine hydrochloride.

Detailed Description
-----------------
To test the effectiveness treating AIDS related depression with imipramine hydrochloride. Depression syndromes are commonly associated with chronic, disabling, and fatal diseases. Due to the relentless course of HIV infection, there is a certain reluctance to treat the associated depression. In other illness, it has been proven that treating the depression often results in improvement of overall health status. This is a placebo controlled trial. Half of the patients are given imipramine hydrochloride every day for 6 weeks. Assessment is done by self reports and the Hamilton Depression Rating Scale. Prior to entry all patients are given a psychiatric evaluation. There is a cross over phase in which placebo non responders are entered into an open-label study and given imipramine hydrochloride.

Conditions
-----------------
Depression

Intervention / Treatment
-----------------
* Drug: Imipramine hydrochloride


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patient must be ambulatory and relatively good health. Even if unable to work at least able to partially care care for self and not demented. May have been alcoholic or drug abuser 6 months previous. Unspecified CD4 Unspecified. Exclusion Criteria: Non ambulatory patients or those requiring extensive help in self care are excluded. Non ambulatory patients or those requiring extensive help in self care are excluded. Current alcohol or drug abuse. Unspecified

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 65 Years

Sexes Eligible for Study
-----------------
All

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment


Arms and Interventions

| Intervention/Treatment |
| --- |
|Drug: Imipramine hydrochloride|nan|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Adult, Acquired Immunodeficiency Syndrome, Depression, Female, Human, Imipramine, Male, Middle Age, Acquired Immunodeficiency Syndrome -- *complications, Depression -- *drug therapy, Depression -- etiology, Imipramine -- *therapeutic use